LegalZoom.com heads into the back half of 2026 with the most telling signal coming not from short sellers, but from its own executives — a cluster of open-market CFO sales in August that landed while the stock was already down sharply from its July levels.
The insider angle is the standout this week. CFO Noel Bertram sold 500,000 shares across August 20 and 21 in two open-market transactions — not under a 10b5-1 plan — at prices of $5.83 and $5.91, collecting roughly $2.95 million in total proceeds. Neither sale was pre-arranged, which makes them more meaningful as a signal. The Chief Legal Officer added smaller planned sales around the same window, also at sub-$6 levels. Net of all transactions in the trailing 90 days, insiders have disposed of 577,475 shares worth $3.4 million. There were no purchases to offset the selling. The CFO's discretionary timing — right after the stock collapsed on earnings — is worth noting.
That collapse is the other defining fact about LZ right now. The August 5 earnings print sent the stock down 32.6% in a single session and 35.4% over the following week, one of the most severe single-print reactions in the company's recent history. The stock traded near $7.21 in early July; it now changes hands at $6.05. This week's tape has been mixed — down 1.3% on the week but up 2.4% on Friday — and the one-month recovery of 11% reflects a partial bounce from post-earnings lows rather than a fundamental re-rating.
Short positioning tells a deliberately cautious but not aggressive story. Short interest is 7% of the free float — meaningful, but down roughly 7% from its late-July peak of around 13.4 million shares. Availability is ample, running near 583%, well above the 52-week floor of 408%. Borrowing costs are minimal at 0.52%, barely moved on the week. The cost-to-borrow did spike briefly to 1.26% on August 31 before collapsing back, a pattern that suggests a brief lending squeeze rather than a structural tightening. The short score of 55.1 is middling — neither a crowded extreme nor a clean cover story. Options traders are equally relaxed. The put/call ratio of 0.33 is fractionally below its 20-day average of 0.33, essentially flat, and well below the 52-week high of 0.78. There is no defensive hedging signal here.
The Street has moved decisively in one direction since earnings. JPMorgan downgraded from Overweight to Neutral on August 6 and cut its target from $8 to $7, following a year of steady target trims — the same analyst had cut from $14 to $11 in February and from $11 to $8 in June. William Blair also downgraded to Market Perform on the same day. Barclays has carried an Underweight since March with a $6 target, and UBS and Citigroup both hold Neutral ratings with targets of $7 to $7.50. The mean price target of $7.60 implies roughly 26% upside from current levels — but that consensus was already being revised sharply lower before the August print, and the as-of date suggests it may not fully reflect post-earnings resets. One genuine counterpoint in the factor scores: forward EPS estimate revisions rank in the 93rd percentile, suggesting analysts who have updated models see earnings improving over the next 12 months even after cutting near-term numbers. The EV/EBITDA multiple of 3.9x and a PE of 7.6x position the stock cheaply — but cheapness in a downgrade cycle tends to reflect risk rather than opportunity.
The next earnings event is flagged for November 6. Between now and then, the question is whether the August traffic and business-formation weakness that triggered the crash was a one-quarter dislocation or a trend — and whether the CFO's August sales at $5.83-$5.91 mark a floor or a ceiling for the recovery attempt.
See the live data behind this article on ORTEX.
Open LZ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
